التفاصيل البيبلوغرافية
| العنوان: |
Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer. |
| المؤلفون: |
Koti, Madhuri, Gooding, Robert J., Nuin, Paulo, Haslehurst, Alexandria, Crane, Colleen, Weberpals, Johanne, Childs, Timothy, Bryson, Peter, Dharsee, Moyez, Evans, Kenneth, Feilotter, Harriet E., Park, Paul C., Squire, Jeremy A. |
| المصدر: |
BMC Cancer; 2013, Vol. 13 Issue 1, p1-22, 22p, 3 Diagrams, 1 Chart, 1 Graph |
| مصطلحات موضوعية: |
OVARIAN cancer treatment, CANCER chemotherapy, EPITHELIAL cells, DRUG resistance in cancer cells, GENE expression, TUMOR markers, OVARIAN cancer patients, THERAPEUTIC use of antineoplastic agents, EPITHELIAL cell tumors, SOMATOMEDIN, RESEARCH, OVARIAN tumors, RESEARCH evaluation, PHOSPHOTRANSFERASES, RESEARCH methodology, MEDICAL cooperation, EVALUATION research, CELLULAR signal transduction, TREATMENT effectiveness, COMPARATIVE studies, DNA-binding proteins, GENES, GENE expression profiling, MOLECULAR structure, CLUSTER analysis (Statistics), TUMOR grading |
| مستخلص: |
Background: Resistance to platinum-based chemotherapy remains a major impediment in the treatment of serous epithelial ovarian cancer. The objective of this study was to use gene expression profiling to delineate major deregulated pathways and biomarkers associated with the development of intrinsic chemotherapy resistance upon exposure to standard first-line therapy for ovarian cancer.Methods: The study cohort comprised 28 patients divided into two groups based on their varying sensitivity to first-line chemotherapy using progression free survival (PFS) as a surrogate of response. All 28 patients had advanced stage, high-grade serous ovarian cancer, and were treated with standard platinum-based chemotherapy. Twelve patient tumours demonstrating relative resistance to platinum chemotherapy corresponding to shorter PFS (< eight months) were compared to sixteen tumours from platinum-sensitive patients (PFS > eighteen months). Whole transcriptome profiling was performed using an Affymetrix high-resolution microarray platform to permit global comparisons of gene expression profiles between tumours from the resistant group and the sensitive group.Results: Microarray data analysis revealed a set of 204 discriminating genes possessing expression levels which could influence differential chemotherapy response between the two groups. Robust statistical testing was then performed which eliminated a dependence on the normalization algorithm employed, producing a restricted list of differentially regulated genes, and which found IGF1 to be the most strongly differentially expressed gene. Pathway analysis, based on the list of 204 genes, revealed enrichment in genes primarily involved in the IGF1/PI3K/NF κB/ERK gene signalling networks.Conclusions: This study has identified pathway specific prognostic biomarkers possibly underlying a differential chemotherapy response in patients undergoing standard platinum-based treatment of serous epithelial ovarian cancer. In addition, our results provide a pathway context for further experimental validations, and the findings are a significant step towards future therapeutic interventions. [ABSTRACT FROM AUTHOR] |
|
Copyright of BMC Cancer is the property of BioMed Central and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder